UNITEPANC: Using organoids to predict efficacy of adjuvant treatment to improve outcome in resectable pancreatic cancer—Prospective, multicenter, proof-of-concept trial of the AIO Pancreatic Cancer Group.
Year: 2025
Type: article
Source: Journal of Clinical Oncology
Institutions: Universität Ulm, University Hospital Ulm, Heidelberg University, Medizinische Fakultät Mannheim, Essen University Hospital, TUM Klinikum, Technical University of Munich, Humboldt-Universität zu Berlin, Freie Universität Berlin, Charité - Universitätsmedizin Berlin, St. Josef-Hospital, Ruhr University Bochum
Language: English
Subfield: Oncology
Field: Medicine
Domain: Health Sciences
Open Access status: closed
Funder: Deutsche Krebshilfe
OpenAlex ID: W4406869728
